Navigation Links
Avrio Receives Drug Manufacturing License and Medical Device Manufacturing License from the California Food and Drug Branch
Date:2/10/2010

IRVINE, Calif., Feb. 10 /PRNewswire/ -- Avrio Biopharmaceuticals, LLC, a wholly-owned subsidiary of Irvine Pharmaceutical Services, Inc., received approval to manufacture and ship pharmaceutical products by the California Department of Public Health, Food and Drug Branch (Cal FDB), completing the organization's portfolio of product development services in support of its pharmaceutical, biopharmaceutical, and medical device clients.  

Avrio's newly built, 20,000 square foot, state-of-the-art, aseptic fill-and-finish facility includes three aseptic suites and five production suites with each suite having its own dedicated air handling system. With great confidence in the newly built infrastructure, strategic manufacturing-process flow, state-of-the-art equipment, and experienced staff, Avrio boasts its level of quality by offering clients live video viewing of production (along with on-site viewing access). In addition to a production area designed to provide clients flexibility and scalability, Avrio also includes laboratory space for quality control, microbiology, formulation, and a pilot suite. Furthermore, Avrio's affiliate, Irvine Pharmaceutical Services, Inc., located just across the street, has over 65,000 square feet of laboratory space which provides complete cGMP analytical CMC support.

With multiple manufacturing contracts in place and a number of agreements underway, Avrio has continued to value the core principles of its affiliate, Irvine Pharmaceutical Services.  "For the past 22 years we have been dedicated to continual improvement of our systems and infrastructures in order to better serve the needs of our clients," said Assad J. Kazeminy, CEO and Founder of Irvine Pharmaceutical Services. "With the addition of Avrio, we can now support our clients from start to finish via a seamless partnership."

You can learn more about Avrio and the executive team at the upcoming 2010 PDA Annual Meeting, booth 714.

About Avrio Biopharmaceuticals, LLC

Avrio Biopharma, an affiliate of Irvine Pharmaceutical Services, is a premier contract development and manufacturing organization providing support to the pharmaceutical, biopharmaceutical, and medical device industries. Avrio, along with its Irvine affiliate, offers full cGMP product development support, specializing in preformulation/formulation, analytical development, process validation, scale-up studies, packaging and labeling, stability storage and complete analytical CMC testing. Learn more at www.avriobiopharma.com or call 866-98-AVRIO (866-982-8746).

SOURCE Avrio Biopharmaceuticals, LLC

RELATED LINKS
http://www.avriobiopharma.com
http://www.irvinepharma.com

'/>"/>

SOURCE Avrio Biopharmaceuticals, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Volcano Receives FDA Clearance to Market the Eagle Eye(R) Platinum Digital IVUS Catheter
2. InteKrin Therapeutics Co-Founder Receives Appointment as Professor of Medicine at Harvard Medical School
3. Novus Scientific Receives FDA Clearance for TIGR(TM) Matrix Surgical Mesh - Worlds 1st Long-Term Resorbable Synthetic Mesh
4. Lillys Online, Interactive Health Education Program Receives Two Web Awards
5. Repligen Receives Notice of Allowance for Recombinant Protein A Patent
6. INNOPHARMA Receives First FDA Approval
7. Pervasis Therapeutics Receives FDA Clearance for Pivotal Phase 3 Trial of Vascugel(R)
8. Mylan Receives Approval for Generic Version of GoLytely(R)
9. Merck Receives European Approval for ELONVA(R) (corifollitropin alfa injection), a New Fertility Treatment
10. Notal Visions ForeseeHome(TM) AMD Monitor Receives FDA Clearance
11. Medicsight PLC Receives Additional Information Request for FDA 510(k) Clearance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/7/2017)... 2017  Diplomat Specialty Infusion Group, a brand of Diplomat Pharmacy, ... Iowa location. The ... features an ISO 7 cleanroom—the standard needed to compound intravenous (IV) ... level of pollutants. "Our new ... better serve our Iowa patients," said ...
(Date:6/2/2017)...  NxStage Medical, Inc. (Nasdaq:  NXTM), a leading medical technology company ... demonstrating positive biochemical outcomes related to more frequent hemodialysis ... will be presented at the ERA-EDTA Congress being held ... . The research was conducted by ... Europe (KIHDNEy) Cohort team ...
(Date:5/30/2017)... AVIV, Israel , May 30, 2017 ... stage pharmaceutical Company specializing in the development of ... will present a company overview at three upcoming ... The 7th Annual LD Micro Invitational: ... Date:                     ...
Breaking Medicine Technology:
(Date:6/23/2017)... , ... June 23, 2017 , ... Ulster University, Magee ... 2017 from 9 am to 3 pm to present to graduate students exciting new ... is an original curriculum project led by The Health Improvement Service of the Western ...
(Date:6/23/2017)... The Woodlands, TX (PRWEB) , ... June 23, ... ... provides families and business owners in the Houston area with access to asset ... Foundation for a regional charity event aimed at improving the lives of children ...
(Date:6/22/2017)... ... 2017 , ... Children’s National Health System has ... launch a Rheumatic Heart Disease Center, with the goal of developing innovative strategies ... (RHD) in high-risk, financially disadvantaged countries and low-income communities across the United States. ...
(Date:6/22/2017)... California (PRWEB) , ... June 23, 2017 , ... ... forces in the fight against hunger on June 21, 2017, at the Emeryville ... fight food insecurity and malnutrition around the world. , Rise Against Hunger (formerly ...
(Date:6/20/2017)... ... 20, 2017 , ... Caduceus International Publishing (CIP), a leading ... new online course entitled Personal & Community Health for the Fall ... achieving optimal well-being and teaches students how to apply them in their everyday ...
Breaking Medicine News(10 mins):